Clinical Trial

Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated December 19, 2017 (before its estimated September 1, 2019 completion). Its status may not reflect the trial's current state.
Summary
Randomized phase II trial aims to compare surgery with or without adjuvant chemotherapy in treating patients who are pathologically diagnosed as stage I lung adenocarcinoma with micropapillary component no less than 20%.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2017-11-20; most recent amendment 2023-01-18.
Status change: Recruiting → Completed 2023-01-18
Trial Details
NCT Number NCT03351842
Lead Sponsor Shanghai Pulmonary Hospital, Shanghai, China
Conditions Chemotherapy, Adjuvant, Lung Adenocarcinoma, Stage I, Treatment, Histological Type of Neoplasm
Enrollment 460 participants
Start Date 2017-09-01
Primary Completion 2019-09-01 (estimated)
Study Completion 2024-09-01 (estimated)
Updated on ClinicalTrials.gov 2017-12-19